Innate Pharma Reports First Half 2021 Financial Results and Business Update

NEXT STORY
Pulmocide’s lead drug candidate opelconazole (PC945) granted Orphan Drug, Fast Track and Qualified Infectious Disease Product Designations by US FDA
PREV STORY
Avalo Therapeutics, Inc. Announces Pricing of $27.5 Million Public Offering of Common Stock
Subscribe to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Orthopedic Implants Market Size to Reach US $64 Billion by 2026; Rising Number of Orthopedic Sports Injuries to Favor Growth

author_avatar
NASDAQ Market News

Men’s Health Month: As Stigmas Surrounding Mental Health Decrease, a Growing Number of Men Seek Psychedelic-Assisted Therapy to Treat a Variety of Mental Illnesses

author_avatar
NASDAQ Market News

MyoKardia Announces Appointment of Denelle J. Waynick as General Counsel and Corporate Secretary

author_avatar
NASDAQ Market News